RBC Capital analyst, Douglas Miehm, noted that the FDA approved Shire's (NASDAQ: SHPG) Xiidra (lifitegrast) as first treatment for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE